[Clinical analysis of a new triphasic estroprogestational combination with gestodene].
New steroidal compounds have been recently synthetized and analysed in order to improve the metabolic tolerance of oral contraception. Gestodene, a new progestogen from the 19 nortestosterone series seems to fulfil these conditions. It has also high antigonadotropic effects. The authors report the clinical results of a study with a triphasic combination containing Gestodene. Despite the small doses of hormones, this triphasic combination with Gestodene provides excellent contraceptive efficacy and good cycle control and clinical tolerance.
Mühe
B
B
Département du contrôle de la fertilité Schering A.G., Berlin.
Vital
M H
MH
D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D009652:Norpregnenes / Q000627:therapeutic use*; D045167:Progesterone Congeners / Q000627:therapeutic use*
D003276:Contraceptives, Oral; D009652:Norpregnenes; D045167:Progesterone Congeners; C033273:Gestodene
Analyse clinique d'une nouvelle association estroprogestative triphasique au gestodène.